TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17061636

Group type: EXPERIMENTAL
Intervention: 5% dextrose in 0.9% normal saline
Number of subjects: 50

Group type: COMPARATOR
Intervention: Lactated Ringer's solution
Number of subjects: 50

Group type: COMPARATOR
Intervention: 0.9% normal saline
Number of subjects: 50
Study: 15069909

Group type: EXPERIMENTAL
Intervention: Internet-based continuing medical education (CME)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Traditional formats of CME
Number of subjects: 16
Study: 11746343

Group type: EXPERIMENTAL
Intervention: Random effects model
Number of subjects: 84

Group type: COMPARATOR
Intervention: Fixed effects model
Number of subjects: 84
Study: 9250453

Group type: EXPERIMENTAL
Intervention: Patient education and system interventions
Number of subjects: 352
Study: 8100184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3752418

Group type: EXPERIMENTAL
Intervention: High dose of birch pollen preparation (n = 11)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (n = 13)
Number of subjects: 24
Study: 31705869

Group type: EXPERIMENTAL
Intervention: Video plus verbal information
Number of subjects: 113

Group type: COMPARATOR
Intervention: Verbal information
Number of subjects: 113
Study: 29742567

Group type: EXPERIMENTAL
Intervention: Er:YAG laser
Number of subjects: 76

Group type: COMPARATOR
Intervention: Traditional bur
Number of subjects: 76
Study: 27916815

Group type: EXPERIMENTAL
Intervention: High intake of Ca-P (n = 30)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Low intake of Ca-P (n = 40)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Low gestational age and male gender
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Protein intake
Number of subjects: 70
Study: 24084157

Group type: EXPERIMENTAL
Intervention: Estimated albumin excretion rate (eAER)
Number of subjects: 1693

Group type: COMPARATOR
Intervention: Urine albumin-creatinine ratio (ACR)
Number of subjects: 1693
Study: 21871811

Group type: EXPERIMENTAL
Intervention: Knee brace
Number of subjects: 58

Group type: COMPARATOR
Intervention: Unbraced condition
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Braced condition
Number of subjects: 58
Study: 18972097

Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 2627

Group type: COMPARATOR
Intervention: Non-HDLC:HDLC ratio
Number of subjects: 2627
Study: 17136309

Group type: EXPERIMENTAL
Intervention: Local Anesthesia (LA)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Spinal Anesthesia (SA)
Number of subjects: 200
Study: 15584360

Group type: EXPERIMENTAL
Intervention: Melitrast-270
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Melitrast-300
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Melitrast-270 and Melitrast-300
Number of subjects: 100
Study: 11222362

Group type: EXPERIMENTAL
Intervention: Dexamethasone and prolonged asparaginase intensification (30 weeks)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Asparaginase treatment duration (at least 26 weeks)
Number of subjects: 377

Group type: EXPERIMENTAL
Intervention: Age at diagnosis
Number of subjects: 377

Group type: COMPARATOR
Intervention: Risk group (standard risk vs high risk)
Number of subjects: 377
Study: 9555799

Group type: EXPERIMENTAL
Intervention: High-dose UVA1 phototherapy (UVA1R; 10 days, 130 J/cm2/day; n = 20)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Topical fluocortolone (10 days, 1 x daily; n = 17)
Number of subjects: 53

Group type: COMPARATOR
Intervention: UVA-UVB therapy (10 days, 1 x daily, minimal erythema dose-dependent; n = 16)
Number of subjects: 53
Study: 7809356

Group type: EXPERIMENTAL
Intervention: Patients with hypochondriasis
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 100
Study: 2903322

Group type: COMPARATOR
Intervention: Tamoxifen (TM), 30 mg daily for 2 years
Number of subjects: 433

Group type: EXPERIMENTAL
Intervention: CMF plus Tamoxifen (TM)
Number of subjects: 433

Group type: COMPARATOR
Intervention: CMF alone
Number of subjects: 433
Study: 6121545

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride administration in neuroleptic-treated schizophrenics
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride administration in total schizophrenic population
Number of subjects: 58

Group type: EXPERIMENTAL
Intervention: Naloxone hydrochloride administration in manic patients
Number of subjects: 58
Study: 31965834

Group type: EXPERIMENTAL
Intervention: UB0316 (probiotic)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 28096659

Group type: EXPERIMENTAL
Intervention: Ponesimod (10 mg, 20 mg, and 40 mg each consecutively for 3 days)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Ponesimod
Number of subjects: 16
Study: 25304864

Group type: EXPERIMENTAL
Intervention: Olanzapine 5 mg
Number of subjects: 129

Group type: EXPERIMENTAL
Intervention: Olanzapine 2.5 mg
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 24700260

Group type: EXPERIMENTAL
Intervention: Orange ice lollies
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Non-citrus ice lollies
Number of subjects: 69

Group type: COMPARATOR
Intervention: Routine treatment (deep breaths)
Number of subjects: 69
Study: 22692271

Group type: EXPERIMENTAL
Intervention: AmF/SnF2 toothpaste twice daily for three minutes and AmF/SnF2 mouthrinse for 30 seconds
Number of subjects: 40

Group type: COMPARATOR
Intervention: AmF/SnF2 toothpaste twice daily for three minutes
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: AmF/SnF2 toothpaste with mouthrinse
Number of subjects: 40

Group type: COMPARATOR
Intervention: AmF/SnF2 toothpaste without mouthrinse
Number of subjects: 40
Study: 19631850

Group type: EXPERIMENTAL
Intervention: Non-surgical endodontic treatment
Number of subjects: 0
Study: 17215184

Group type: EXPERIMENTAL
Intervention: Intervention villages (traditional food intervention)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control villages (no intervention)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mothers from intervention villages
Number of subjects: 0
Study: 15224028

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (100 mg/kg into cardiopulmonary bypass prime followed by infusion at 20 mg.kg(‐1).h(‐1); n = 18)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo (n = 18)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: COMPARATOR
Intervention: N-acetylcysteine and placebo
Number of subjects: 36
Study: 12169328

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Schizophrenic group
Number of subjects: 21
Study: 9848039

Group type: EXPERIMENTAL
Intervention: Glycerol preservation (70% and 85%)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Glycerol preservation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cryopreservation (10% dimethyl sulfoxide)
Number of subjects: 0
Study: 8026205

Group type: EXPERIMENTAL
Intervention: Continuous postural therapy on an oscillating bed
Number of subjects: 19

Group type: COMPARATOR
Intervention: Conventional frequency of manual postural changes (Control)
Number of subjects: 19
Study: 2690332

Group type: EXPERIMENTAL
Intervention: Omeprazole, 30 mg once daily
Number of subjects: 176

Group type: COMPARATOR
Intervention: Cimetidine, 200 mg t.d.s. and 400 mg at bedtime
Number of subjects: 176
Study: 1015496

Group type: EXPERIMENTAL
Intervention: 10 mg of metoclopramide intravenously
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (sodium metabisulfite) intravenously
Number of subjects: 49
Study: 31031045

Group type: EXPERIMENTAL
Intervention: Radiofrequency (pulsed and conventional) on the saphenous nerve and genicular nerves
Number of subjects: 28

Group type: COMPARATOR
Intervention: Placebo (PLCB)
Number of subjects: 28
Study: 28823684

Group type: COMPARATOR
Intervention: Light exercise
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Vigorous exercise
Number of subjects: 620

Group type: EXPERIMENTAL
Intervention: Moderate exercise
Number of subjects: 620

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 620
Study: 25960826

Group type: EXPERIMENTAL
Intervention: DHA supplementation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Vitamin C (VitC) supplementation
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: DHA and VitC supplementation together
Number of subjects: 15

Group type: COMPARATOR
Intervention: PMA activation
Number of subjects: 15
Study: 23213004

Group type: EXPERIMENTAL
Intervention: Etanercept and methotrexate (ETN + MTX)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care (various DMARDs)
Number of subjects: 62
Study: 21768764

Group type: EXPERIMENTAL
Intervention: Universal screening for MRSA using polymerase chain reaction (PCR) on samples collected from all adult patients upon admission.
Number of subjects: 15049

Group type: COMPARATOR
Intervention: Targeted screening for MRSA conducted during a 9-month baseline period.
Number of subjects: 15049
Study: 19500083

Group type: EXPERIMENTAL
Intervention: Kangaroo Mother Care
Number of subjects: 338

Group type: COMPARATOR
Intervention: Traditional Care
Number of subjects: 338
Study: 17483854

Group type: EXPERIMENTAL
Intervention: Care recipients often visit physicians or have medical examinations
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care recipients take medicines that affect the central nervous system or stomach
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Care recipients seldom visit nurses
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caregivers have chronic disease or cancer
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caregiver experience distress, feel lonely, or have an unsatisfactory relationship with patients
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Caregiver's smoking and drinking
Number of subjects: 0
Study: 15454833

Group type: EXPERIMENTAL
Intervention: MSC (Avemar) with cytotoxic drugs
Number of subjects: 22

Group type: COMPARATOR
Intervention: Control (cytotoxic drugs without MSC)
Number of subjects: 22
Study: 11406737

Group type: EXPERIMENTAL
Intervention: Rifampin 600 mg once daily for 5 days
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 9803198

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for cough or bronchitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Empiric treatment for pharyngitis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment for common cold
Number of subjects: 0
Study: 7816388

Group type: EXPERIMENTAL
Intervention: Gallbladder sludge
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Gallstones
Number of subjects: 51

Group type: COMPARATOR
Intervention: Normal gallbladders
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Gallbladder sludge or stones
Number of subjects: 51
Study: 3049216

Group type: EXPERIMENTAL
Intervention: Recombinant human alpha-interferon therapy (4-month duration)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Recombinant human alpha-interferon therapy
Number of subjects: 45
Study: 31486917

Group type: EXPERIMENTAL
Intervention: Total keratometry (TK)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional keratometry (K)
Number of subjects: 60
Study: 28482869

Group type: EXPERIMENTAL
Intervention: Intravenous iron sucrose (200 mg per day in 100 ml 0.9% sodium chloride)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Oral ferrous fumarate (200 mg per day)
Number of subjects: 112
Study: 25501671

Group type: EXPERIMENTAL
Intervention: Brivaracetam 150 mg/day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Brivaracetam 5 mg/day
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Brivaracetam 50 mg/day
Number of subjects: 42
Study: 23296713

Group type: EXPERIMENTAL
Intervention: Active LLLT (808 nm wavelength, 100 mW, energy 7 J)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo LLLT
Number of subjects: 24
Study: 21701181

Group type: EXPERIMENTAL
Intervention: Art therapy intervention
Number of subjects: 74

Group type: COMPARATOR
Intervention: Dropouts
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Art therapist and supervisor perspectives
Number of subjects: 74
Study: 18253828

Group type: EXPERIMENTAL
Intervention: Granulocyte/monocyte apheresis (GMCAP)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Adacolumn apheresis
Number of subjects: 13
Study: 16490980

Group type: EXPERIMENTAL
Intervention: Topical povidone-iodine (Betadine) with compression bandages
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Topical povidone-iodine (Betadine) without compression bandages
Number of subjects: 63

Group type: COMPARATOR
Intervention: Systemic antibiotics (amoxicillin)
Number of subjects: 63

Group type: EXPERIMENTAL
Intervention: Topical povidone-iodine (Betadine)
Number of subjects: 63
Study: 12601503

Group type: EXPERIMENTAL
Intervention: 100 mg caffeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 50 mg caffeine
Number of subjects: 0

Group type: COMPARATOR
Intervention: No caffeine
Number of subjects: 0
Study: 10834429

Group type: EXPERIMENTAL
Intervention: Repaglinide (0.5 mg)
Number of subjects: 8
Study: 9533322

Group type: EXPERIMENTAL
Intervention: Metronidazole-plus-debridement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo-plus-debridement
Number of subjects: 0
Study: 8450096

Group type: EXPERIMENTAL
Intervention: Social support
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Discussion
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: No shows
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-contact control
Number of subjects: 0
Study: 3512352

Group type: EXPERIMENTAL
Intervention: Pentasa (slow-release 5'-aminosalicylic acid)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 29277312

Group type: EXPERIMENTAL
Intervention: Subcostal transversus abdominis plane block
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard postoperative analgesia
Number of subjects: 76
Study: 27811457

Group type: EXPERIMENTAL
Intervention: Carbohydrate‐rich drink group (Group C, n = 30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Preoperative fasting from midnight (Group F, n = 30)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo drink group (Group P, n = 30)
Number of subjects: 90
Study: 24365552

Group type: EXPERIMENTAL
Intervention: Generic three-drug FDC formulation (3FDC)
Number of subjects: 20

Group type: COMPARATOR
Intervention: 3FDC reference formulation
Number of subjects: 20
Study: 23405793

Group type: EXPERIMENTAL
Intervention: Compound Xuanju Capsule plus apomorphine hydrochloride
Number of subjects: 226

Group type: COMPARATOR
Intervention: Apomorphine hydrochloride alone
Number of subjects: 226
Study: 20461810

Group type: EXPERIMENTAL
Intervention: Ropinirole prolonged release (2-24 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 17716952

Group type: EXPERIMENTAL
Intervention: Motivational and life skills intervention
Number of subjects: 1560

Group type: COMPARATOR
Intervention: General health education program
Number of subjects: 1560
Study: 15949913

Group type: EXPERIMENTAL
Intervention: Mobile monitoring system for foetal cardiotachometry
Number of subjects: 25
Study: 12728300

Group type: EXPERIMENTAL
Intervention: L-tryptophan infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 20
Study: 10569654

Group type: COMPARATOR
Intervention: Micronized fenofibrate
Number of subjects: 418
Study: 9061426

Group type: EXPERIMENTAL
Intervention: Irrigating fluid absorption during TURP
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Choice of crystalloid or colloid solution for intravenous fluid supplementation
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Presence of cardiac disease
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: Impaired kidney function and serum cortisol concentration
Number of subjects: 35
Study: 1855356

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study: 6360031

Group type: EXPERIMENTAL
Intervention: 10 to 15 mg oral physostigmine daily
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31800477

Group type: EXPERIMENTAL
Intervention: Massage
Number of subjects: 48

Group type: COMPARATOR
Intervention: CWI
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study: 30503044

Group type: EXPERIMENTAL
Intervention: Dolutegravir plus lamivudine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dolutegravir plus tenofovir disoproxil fumarate and emtricitabine
Number of subjects: 0
Study: 29507944

Group type: COMPARATOR
Intervention: Standard blood pressure control (systolic target 130-140 mm Hg)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure control (systolic target <125 mm Hg)
Number of subjects: 70
Study: 27343566

Group type: EXPERIMENTAL
Intervention: Phase-rectified signal averaging
Number of subjects: 279

Group type: COMPARATOR
Intervention: Short-term variation
Number of subjects: 279

Group type: EXPERIMENTAL
Intervention: Phase-rectified signal averaging and short-term variation
Number of subjects: 279
Study: 25716389

Group type: EXPERIMENTAL
Intervention: Pelvic muscle exercises
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 50
Study: 22980127

Group type: EXPERIMENTAL
Intervention: Ischemia modified albumin (IMA) levels measured before and after treadmill test
Number of subjects: 56
Study: 19854793

Group type: EXPERIMENTAL
Intervention: Clonidine (0.5 microg/kg bolus, followed by continuous infusion at 1‐2 microg/kg/h)
Number of subjects: 30
Study: 17388769

Group type: EXPERIMENTAL
Intervention: True acupressure
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sham acupressure
Number of subjects: 44
Study: 15617992

Group type: EXPERIMENTAL
Intervention: High-dose chemotherapy (HD-CT) using the CMA regimen (Mitoxantrone, Cyclophosphamide, Melphalan)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Conventional chemotherapy (CT)
Number of subjects: 61
Study: 12208242

Group type: EXPERIMENTAL
Intervention: Optic nerve sheath decompression surgery
Number of subjects: 418

Group type: COMPARATOR
Intervention: Careful follow-up
Number of subjects: 418
Study: 10362194

Group type: EXPERIMENTAL
Intervention: Aspirin and ACE inhibitors
Number of subjects: 11575

Group type: COMPARATOR
Intervention: ACE inhibitors without aspirin
Number of subjects: 11575

Group type: EXPERIMENTAL
Intervention: Aspirin and ACE inhibitors in congestive heart failure patients
Number of subjects: 11575

Group type: COMPARATOR
Intervention: ACE inhibitors without aspirin in congestive heart failure patients
Number of subjects: 11575
Study: 7589340

Group type: EXPERIMENTAL
Intervention: 13‐cis‐retinoic acid (10 to 60 mg/m2/daily) administered in combination with vitamin E for 3 months to 5 years
Number of subjects: 34
Study: 2119982

Group type: EXPERIMENTAL
Intervention: Norplant-2
Number of subjects: 200

Group type: COMPARATOR
Intervention: Levonorgestrel-releasing IUD (LNG-IUD)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 200
Study: 474345

Group type: EXPERIMENTAL
Intervention: Feedback goniometers used during active range-of-motion exercises
Number of subjects: 0
Study: 31995576

Group type: EXPERIMENTAL
Intervention: Admixture and mtDNA tests
Number of subjects: 0

Group type: COMPARATOR
Intervention: No tests
Number of subjects: 0
Study: 31354000

Group type: EXPERIMENTAL
Intervention: HIGH (supervised, multimodal exercise including heavy-load resistance exercise: 85-90% 1 repetition maximum [RM], three sets of 5-8 repetitions)
Number of subjects: 153

Group type: COMPARATOR
Intervention: LOW (pedometer and one-on-one consultations)
Number of subjects: 153
Study: 28743191

Group type: EXPERIMENTAL
Intervention: Electronic patient-reported outcome diary
Number of subjects: 311
Study: 28352711

Group type: EXPERIMENTAL
Intervention: SLING-IUFT
Number of subjects: 154

Group type: COMPARATOR
Intervention: TVT-Exact
Number of subjects: 154
Study: 23278879

Group type: EXPERIMENTAL
Intervention: Dietary intervention
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Combined dietary and exercise intervention
Number of subjects: 46
Study: 21525520

Group type: EXPERIMENTAL
Intervention: 500,000 IU vitamin D(3) (cholecalciferol) orally every autumn/winter for 3-5 consecutive years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 500,000 IU vitamin D(3) (cholecalciferol)
Number of subjects: 0
Study: 19387807

Group type: EXPERIMENTAL
Intervention: Protocol A - Enoxaparin 1 mg/kg x ten doses
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Protocol B - Enoxaparin 1 mg/kg x six doses
Number of subjects: 539

Group type: EXPERIMENTAL
Intervention: Protocol C - Enoxaparin 0.5 mg/kg x six doses
Number of subjects: 539
Study: 16965205

Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medications (CPMs) - antidepressants
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medications (CPMs) - mood stabilizers
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medications (CPMs) - modafinil and trazodone
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Concomitant psychotropic medications (CPMs) - sleeping medications
Number of subjects: 53
Study: 15225174

Group type: EXPERIMENTAL
Intervention: Non-erosive reflux disease
Number of subjects: 145

Group type: COMPARATOR
Intervention: Functional heartburn
Number of subjects: 145
Study: 12419032

Group type: EXPERIMENTAL
Intervention: rLH supplementation with rFSH (Group A)
Number of subjects: 453

Group type: COMPARATOR
Intervention: rFSH only (Group B)
Number of subjects: 453
Study: 9523960

Group type: EXPERIMENTAL
Intervention: Initial injection into the midcarpal and distal radioulnar joints
Number of subjects: 100

Group type: COMPARATOR
Intervention: Initial injection into the radiocarpal joint
Number of subjects: 100
Study: 7660509

Group type: EXPERIMENTAL
Intervention: Oral face‐to‐face interview
Number of subjects: 475

Group type: EXPERIMENTAL
Intervention: Telephone interview
Number of subjects: 475

Group type: COMPARATOR
Intervention: Self‐administered questionnaires
Number of subjects: 475
Study: 2625214

Group type: EXPERIMENTAL
Intervention: Right forced unilateral nostril breathing (FUNB)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Left forced unilateral nostril breathing (FUNB)
Number of subjects: 0